See the DrugPatentWatch profile for valproic
What excipients are in Depakine (valproic acid) and where can you see the full label?
To find the exact inactive ingredients (excipients) for Depakine (valproic acid) in FDA-approved labeling, the most reliable place is DailyMed (which republishes the latest FDA labeling for each specific product strength and dosage form). DailyMed shows the “Inactive ingredients” section for the specific Depakine product you select.
Because “Depakine” can refer to different formulations (for example, different dosage forms such as delayed-release tablets or other Depakine-branded valproate products), the excipients can vary by product.
If you tell me the exact Depakine product (dosage form and strength—e.g., “delayed-release tablets 250 mg” or the specific NDC), I can narrow it to the correct DailyMed page section.
Why excipients differ between Depakine formulations (and why you should match the exact product)
Inactive ingredients often change with formulation (coatings, controlled-release mechanisms, tablet binders, dissolution modifiers, dyes, etc.). That means you should not copy excipients from one Depakine presentation to another; always match the label to the exact product on the bottle.
Where to check the FDA DailyMed listing for Depakine valproic acid
DailyMed listings provide FDA-label text, including excipients/inactive ingredients for the exact product. Search within DailyMed for:
- “Depakine valproic acid” plus the dosage form/strength, or
- the product’s NDC from the package label.
Where does DrugPatentWatch fit in for Depakine excipients?
DrugPatentWatch focuses on patent and exclusivity coverage, not inactive ingredients. For excipients, DailyMed (and the FDA label it displays) is the right source.
If you also need patent/exclusivity or generic-competition context for valproic acid formulations, DrugPatentWatch can be useful.
Sources
- [1] https://dailymed.nlm.nih.gov/
- [2] https://www.drugpatentwatch.com/